Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 26, 2003, Pages 15871-15876

  Johns, Terrance G ^a   Luwor, Rodney B ^a   Murone, Carmel ^a   Walker, Francesca ^b   Weinstock, Janet ^b   Vitali, Angela A ^a   Perera, Rushika M ^a   Jungbluth, Achim A ^c   Stockert, Elisabeth ^c   Old, Lloyd J ^c   Nice, Edouard C ^b   Burgess, Antony W ^b   Scott, Andrew M ^a  

^a AUSTIN HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 806; PROTEIN TYROSINE KINASE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; ENZYME INHIBITION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; DRUG SYNERGISM; ENZYME INHIBITORS; GLIOMA; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 9144229553     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2036503100     Document Type: Article

References (31)

1. Mendelsohn, J. (2002) J. Clin. Oncol. 20, 1S-13S.
2. Arteaga, C. L. (2002) Semin. Oncol. 29, 3-9.
3. Nicholson, R. I., Gee, J. M. & Harper, M. E. (2001) Eur. J. Cancer 37, Suppl. 4, S9-S15.
4. de Bono, J. S. & Rowinsky, E. K. (2002) Trends Mol. Med. 8, S19-S26.
5. Herbst, R. S. & Shin, D. M. (2002) Cancer 94, 1593-1611.
6. Wakeling, A. E. (2002) Curr. Opin. Pharmacol. 2, 382-387.
7. Yaish, P., Gazit, A., Gilon, C. & Levitzki, A. (1988) Science 242, 933-935.
8. Jungbluth, A. A., Stockert, E., Huang, H. J., Collins, V. P., Coplan, K., Iversen, K., Kolb, D., Johns, T. J., Scott, A. M., Gullick, W. J., et al. (2003) Proc. Natl. Acad. Sci; USA 100, 639-644.
9. Johns, T. G., Stockert, E., Ritter, G., Jungbluth, A. A., Huang, H. J., Cavenee, W.K., Smyth, F. E., Hall, C. M., Watson, N., Nice, E. C., et al. (2002) Int. J. Cancer 98, 398-408.
10. Luwor, R. B., Johns, T. G., Murone, C., Huang, H. J., Cavenee, W. K., Ritter, G., Old, L. J., Burgess, A. W. & Scott, A. M. (2001) Cancer Res. 61, 5355-5361.
11. Mishima, K., Johns, T. G., Luwor, R. B., Scott, A. M., Stockert, E., Jungbluth, A. A., Ji, X. D., Suvarna, P., Voland, J. R., Old, L. J., et al. (2001) Cancer Res. 61, 5349-3354.
12. Han, Y., Caday, C. G., Nanda, A., Cavenee, W. K. & Huang, H. J. (1996) Cancer Res. 56, 3859-3861.
13. Wikstrand, C. J., Reist, C. J., Archer, G. E., Zalutsky, M. R. & Bigner, D. D. (1998) J. Neurovirol. 4, 148-158.
14. Sugawa, N., Ekstrand, A. J., James, C. D. & Collins, V. P. (1990) Proc. Natl. Acad. Sci; USA 87, 8602-8606.
15. Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K. & Huang, H. J. (1994) Proc. Natl. Acad. Sci. USA 91, 7727-7731.
16. Tang, C. K., Gong, X. Q., Moscatello, D. K., Wong, A. J. & Lippman, M. E. (2000) Cancer Res. 60, 3081-3087.
17. Friedman, H. S., Kerby, T. & Calvert, H. (2000) Clin. Cancer Res. 6, 2585-2597.
18. Kwok, T. T. & Sutherland, R. M. (1991) Br. J. Cancer 64, 251-254.
19. Walker, F., Hibbs, M. L., Zhang, H. H., Gonez, L. J. & Burgess, A. W. (1998) Growth Factors 16, 53-67.
20. Ellis, A. G., Nice, E. C., Weinstock, J., Levitzki, A., Burgess, A. W. & Webster, L. K. (2001) J. Chromatogr. B Biomed. Sci. Appl. 754, 193-199.
21. Schooler, K. & Wiley, H. S. (2000) Anal. Biochem. 277, 135-142.
22. Bishop, P. C., Myers, T., Robey, R., Fry, D. W., Liu, E. T., Blagosklonny, M. V. & Bates, S. E. (2002) Oncogene 21, 119-127.
23. DeWitt, A. E., Dong, J. Y., Wiley, H. S. & Lauffenburger, D. A. (2001) J. Cell Sci. 114, 2301-2313.
24. Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., Sundberg, C. D., Bishop, J. M. & Felsher, D. W. (2002) Science 297, 102-104.
25. Nagane, M., Narita, Y., Mishima, K., Levitzki, A., Burgess, A. W., Cavenee, W. K. & Huang, H. J. (2001) J. Neurosurg. 95, 472-479.
26. Heimberger, A. B., Learn, C. A., Archer, G. E., McLendon, R. E., Chewning, T. A., Tuck, F. L., Pracyk, J. B., Friedman, A. H., Friedman, H. S., Bigner, D. D. & Sampson, J. H. (2002) Clin. Cancer Res. 8, 3496-3502.
27. Siromak, F. M., Zakowski, M. F., Miller, V. A., Scher, H. I. & Kris, M. G. (2000) Clin. Cancer Res. 6, 4885-4892.
28. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Pomatico, G., De Placido, S., Bianco, A. R. & Tortora, G. (2000) Clin Cancer Res. 6, 2053-2063.
29. Bos, M., Mendelsohn, J., Kim, Y. M., Albanell, J., Fry, D. W. & Baselga, J. (1997) Clin. Cancer Res. 3, 2099-2106.
30. Arteaga, C. L., Ramsey, T. T., Shawver, L. K. & Guyer, C. A. (1997) J. Biol. Chem. 272, 23247-23254.
31. Lichtner, R. B., Menrad, A., Sommer, A., Klar, U. & Schneider, M. R. (2001) Cancer Res. 61, 5790-5795.